Effect Of Low Dose Bortezomib On Bone Formation In Smoldering Myeloma Patients
Maurizio Zangari(University of Arkansas for Medical Sciences), Fenghuang Zhan(Winthrop Rockefeller Foundation), Tamara Berno(University of Padua), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Scott C. Miller(University of Utah), Karen Pena(Huntsman Cancer Institute), Sherjeel Sana(Abu Dhabi Health Services), Giampaolo Talamo(University of Perugia)
Cited by 6
Related Papers
Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
|Cancer Cell|2007|949
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484